Annals of Medicine and Surgery, 2022 · DOI: https://doi.org/10.1016/j.amsu.2022.104889 · Published: November 13, 2022
Amyotrophic lateral sclerosis (ALS) is a rare disease affecting nerve cells in the brain and spinal cord. Early diagnosis is crucial for managing bulbar onset ALS, which affects speech and swallowing. This case report details a 60-year-old female presenting with slurred speech and difficulty swallowing. Diagnostic tools like MRI, EMG, and NCS were used to confirm ALS. Effective treatment of ALS requires a team of specialists, including neurologists and speech therapists. Edaravone, an antioxidant, can help reduce neuronal injury in ALS patients.
Highlights the importance of early and accurate diagnosis of bulbar onset ALS to improve patient outcomes.
Emphasizes the need for a collaborative approach involving neurologists, speech therapists, and other specialists in ALS management.
Suggests Edaravone as a potential treatment option to counteract oxidative stress and neuronal injury in ALS patients.